Genrui Biotech Showcases Range of Clinical Diagnostic Instruments at MEDICA 2026
Posted on 18 Nov 2026
Genrui Biotech (Shenzhen, China) is showcasing its clinical diagnostic instruments at MEDICA 2026, taking place November 16–19 in Düsseldorf, Germany. Among the featured products are the KT-8000 five-part differential hematology analyzer, FA50, FA30, and FA20 quantitative immunoassay analyzers, and PA240 fully automated specific protein analyzer. These instruments support hematology, point-of-care testing, immunoassays, and specific protein measurement.
Among the featured products is the KT-8000 5-Diff Hematology Analyzer, a fully automated system equipped with an automatic sample loader and mixer to reduce manual handling and extend walk-away time. The analyzer incorporates a smart counting mode, supports both open-vial and automatic loading modes, and allows priority processing of emergency samples. An integrated data management system helps streamline laboratory workflows.

Genrui is also presenting its FA50 quantitative immunofluorescence analyzer, a point-of-care testing (POCT) system suitable for clinics, physicians' offices, and hospital departments such as intensive care units. The analyzer supports whole blood, serum, and plasma samples and features magnetic card-based automatic calibration. Another featured product is the FA30, which offers 12 independent testing channels with individual temperature control, a 10.1-inch touchscreen, and a maintenance-free design without internal liquid pathways. The system is intended for medium-sized laboratories processing approximately 30 samples daily.
The company is also highlighting the FA20, a compact, portable quantitative immunoassay analyzer that supports fingerstick blood testing and delivers results in approximately 3 or 10 minutes, depending on the assay. It uses disposable consumables to minimize cross-contamination and features magnetic card calibration and a rechargeable lithium battery supporting up to 10 hours of continuous operation.
Also featured is the PA240 Fully-Auto Specific Protein Analyzer, which combines colorimetry and nephelometry to support testing across clinical areas such as renal function, rheumatology, immunoglobulins, inflammation, and glucose metabolism. Its dual-method approach expands the assay menu to accommodate different laboratory requirements. These instruments form part of Genrui's broader portfolio of automated and point-of-care diagnostic technologies.







